Try our Advanced Search for more refined results

Expert Analysis

3 Antitrust Cases Drug Companies Should Watch This Year

By Chad Peterman and Carl Minniti (January 18, 2018, 1:33 PM EST) -- The intersection of complex drug competition frameworks and the antitrust laws continues to grow. With increased collaboration between the U.S. Food and Drug Administration and the Federal Trade Commission on the horizon, acts taken in the life sciences industry may be under greater scrutiny.[1] In this article, we discuss three cases to watch in 2018 as antitrust principles impacting pharmaceutical companies continue to develop....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!